About Syntiron

November 24, 2008 at 5:01AM

Business: The company is developing a vaccine that can treat a wide range of bacterial diseases, including anthrax and bubonic plague. Headquarters: St. Paul

Chairman and CEO: Joe Shaw

Revenue: None so far

Employees: nine

about the writer

about the writer

More from Business

See More
card image
Aaron Nesheim/Sahan Journal

Nonprofit leaders say they have had to lay off staff and take other measures to shore up finances as the Trump administration’s attacks on diversity, equity and inclusion efforts have chilled corporate giving and led to cuts in federal and state grants.

card image
card image